RPS6KB1 and breast cancer: The chromosomal region 17q23 containing the p70S6K gene (RPS6KB1) is amplified in approximately 10% of all primary breast cancer cases, leading to p70S6K overexpression [16–19] and this amplification is associated with poor prognosis [16,20–22].